DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
11.25
-0.02 (-0.18%)
At close: Dec 5, 2025, 4:00 PM EST
11.23
-0.02 (-0.17%)
After-hours: Dec 5, 2025, 7:52 PM EST
DENTSPLY SIRONA Revenue
DENTSPLY SIRONA had revenue of $904.00M in the quarter ending September 30, 2025, a decrease of -4.94%. This brings the company's revenue in the last twelve months to $3.62B, down -7.08% year-over-year. In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%.
Revenue (ttm)
$3.62B
Revenue Growth
-7.08%
P/S Ratio
0.62
Revenue / Employee
$258,857
Employees
14,000
Market Cap
2.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
| Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
| Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
| Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
| Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
| Dec 31, 2019 | 4.02B | 36.00M | 0.90% |
| Dec 31, 2018 | 3.99B | -7.40M | -0.19% |
| Dec 31, 2017 | 3.99B | 248.10M | 6.62% |
| Dec 31, 2016 | 3.75B | 1.07B | 40.05% |
| Dec 31, 2015 | 2.67B | -248.30M | -8.50% |
| Dec 31, 2014 | 2.92B | -28.20M | -0.96% |
| Dec 31, 2013 | 2.95B | 22.37M | 0.76% |
| Dec 31, 2012 | 2.93B | 390.71M | 15.40% |
| Dec 31, 2011 | 2.54B | 316.70M | 14.26% |
| Dec 31, 2010 | 2.22B | 61.64M | 2.85% |
| Dec 31, 2009 | 2.16B | -32.09M | -1.46% |
| Dec 31, 2008 | 2.19B | 181.63M | 9.04% |
| Dec 31, 2007 | 2.01B | 199.34M | 11.01% |
| Dec 31, 2006 | 1.81B | 95.36M | 5.56% |
| Dec 31, 2005 | 1.72B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
XRAY News
- 23 days ago - 3 Healthcare Stocks Topping a 2025 List of Dividend Yields - The Motley Fool
- 26 days ago - Brickwood Asset Management Adds $19 Million in Dentsply Sirona (NASDAQ: XRAY) Shares: Should Investors Buy the Turnaround Stock? - The Motley Fool
- 4 weeks ago - Dentsply Sirona Stock Sinks On Missed Expectations, Lowered 2025 Guidance; CEO Unveils Return-To-Growth Plan - Benzinga
- 4 weeks ago - DENTSPLY SIRONA Inc. (XRAY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Dentsply Sirona Reports Third Quarter 2025 Results - GlobeNewsWire
- 6 weeks ago - Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 2 months ago - Dentsply Sirona to Host Third Quarter Conference Call on November 6th - GlobeNewsWire
- 2 months ago - Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization - GlobeNewsWire